載入...
Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline
Oral and intravenous (IV) omadacycline formulations are approved in the United States for treating acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia in adults. Oral omadacycline bioavailability is 34.5%; similar exposures are obtained following 300 mg oral...
Na minha lista:
| 發表在: | Clin Infect Dis |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6669312/ https://ncbi.nlm.nih.gov/pubmed/31367744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz309 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|